Use of the Andrew+ Robot and OneLab Automated Liquid Handling Platform for Bacterial Endotoxin Testing

March 25th, 2021 • 8 a.m. PT, 11 a.m. ET

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

A bacterial endotoxin test (BET) is a requirement for any injectable drug or medical device to ensure safety. This can be accomplished by performing a Limulus Amebocyte Lysate (LAL) based in vitro endotoxin detection assay such as Pyrochrome®.

This 96 well microplate based kinetic chromogenic assay is accomplished through numerous pipetting steps required for the preparation of the standard curve positive and product controls (PPCs). Placement of the samples and standards, and reagent dispensing in the 96 well plates are tedious steps in the process.

The complexity of these assays would benefit from the simplicity and labor saving benefits of accessible liquid handling methods. In this webinar we will demonstrate the simplicity and accessibility of the Andrew+ Pipetting Robot working together with OneLab software executing the Pyrochrome® assay. We will present an overview of the Pyrochrome® assay configuration, the method, and results generated with Andrew+ and OneLab.

In this webinar you’ll learn:

• How the Andrew+ and OneLab can be configured to execute the Pyrochrome® kinetic chromogenic assay

• Results of evaluating Andrew+ Pipetting Robot and OneLab automation of the Pyrochrome® kinetic chromogenic assay

• Benefits of automating LAL based endotoxin testing methods

Who should attend:

• Laboratory Managers

• Quality Control Managers

• Assay Development Scientists

• Quality Control Analysts

Presenters

Presenter
Robert D’Ordine Ph.D.
(Presenter)
Senior Research Scientist
Associates of Cape Cod, Inc. (ACC)
View Biography
Presenter
Veronika Wills
(Presenter)
Technical Services Manager
Associates of Cape Cod, Inc. (ACC)
View Biography
Presenter
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review